Lymph node evaluation and survival in colorectal cancer: Review of population-based, prospective studies

Anticancer Research

Volumn 33, Issue 7, 2013, Pages 2839-2848

  Akagi, Yoshito ^a   Adachi, Yosuke ^a   Kinugasa, Tetsushi ^a   Oka, Yosuke ^a   Mizobe, Tomoaki ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Lymph node harvest; Lymph node metastasis; Lymph node ratio; Population based study; Prospective study; Review; Survival

Indexed keywords

AGE DISTRIBUTION; BODY MASS; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CASE STUDY; CHEMORADIOTHERAPY; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL STUDY; COLON RESECTION; COLORECTAL CANCER; CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE SPECIFIC SURVIVAL; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE HARVEST; LYMPH NODE RATIO; META ANALYSIS; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; POPULATION RESEARCH; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; SEX DIFFERENCE; SURVIVAL RATE; SYSTEMATIC REVIEW; TUMOR VOLUME; UNIVERSITY HOSPITAL;

COLORECTAL CANCER; LYMPH NODE HARVEST; LYMPH NODE METASTASIS; LYMPH NODE RATIO; POPULATION-BASED STUDY; PROSPECTIVE STUDY; REVIEW; SURVIVAL;

COLORECTAL NEOPLASMS; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; UNITED STATES;

EID: 84882593763     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (101)

1. Cueto CV, Szeja S, Wertheim BC, Ong ES and Tsikitis VL: Disparities in treatment and survival of white and native American patients with colorectal cancer: A SEER analysis. J Am Coll Surg 213: 469-474, 2011.
2. Coleman MP, Forman D, Bryart H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J and Richards MA: Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): An analysis of population-based cancer registry data. Lancet 377: 127-138, 2011.
3. Morris EJ, Sandin F, Lambert PC, Bray F, Klint A, Linklater K, Robinson D, Pahlman L, Holmberg L and Moller H: A population based comparison of the survival of patients with colorectal cancer in England, Norway and Sweden between 1996 and 2004. Gut 60: 1087-1093, 2011.
4. Schofield JB, Mounter NA, Mallett R and Haboubi NY: The importance of accurate pathological assessment of lymph node involvement in colorectal cancer (review). Colorectal Dis 8: 460-470, 2006.
5. Wright FC, Law CHL, Berry S and Smith AJ: Clinically important aspects of lymph node assessment in colon cancer (review). J Surg Oncol 99: 248-255, 2009.
6. Shia J, Wang H, Nash GM and Klimstra DS: Lymph node staging in colorectal cancer: revisiting the benchmark of at least 12 lymph nodes in R0 resection. J Am Coll Surg 214: 348-355, 2012.
7. Sarli L, Bader G, Iusco D, Salvemini C, Mauro DD, Mazzeo A, Regina G and Roncoroni L: Number of lymph nodes examined and prognosis of TNM II colorectal cancer. Eur J Cancer 41: 272-279, 2005.
8. Ostadi MA, Harnish JL, Stegienko S and Urbach DR: Factors affecting the number of lymph nodes retrived in colorectal cancer specimens. Surg Endosc 21: 2142-2146, 2007.
9. Jakub JW, Russell G, Tillman CL and Lariscy C: Colon cancer and low lymph node count: who is to blame? Arch Surg 144: 1115-1120, 2009.
10. Senthil M, Trisal V, Paz IB and Lai LL: Prediction of the adequacy of lymph node retrieval in colon cancer by hospital type. Arch Surg 145: 840-843, 2010.
11. Linebarger JH, Mathiason MA, Kallies KJ and Shapiro SB: Does obesity impact lymph node retrieval in colon cancer surgery? Am J Surg 200: 478-482, 2010.
12. Peeples C, Shellnut J, Wasvary H, Peeples C, Shellnut J, Wasvary H, Riggs T and Sacksner J: Predictive factors affecting survival in stage II colorectal cancer: Is lymph node harvesting relevant? Dis Colon Rectum 53: 1517-1523, 2010.
13. Wright FC, Law CH, Last L, Khalifa M, Arnaout A, Naseer Z, Klar N, Gallinger S and Smith AJ: Lymph node retrieval and assessment in stage II colorectal cancer: A population-based study. Ann Surg Oncol 10: 903-909, 2003.
14. Tekkis PP, Smith JJ, Heriot AG, Darzi AW, Thompson MR and Stamatakis JD: Association of Coloproctology of Great Britain and Ireland. A national study on lymph node retrieval in resectional surgery for colorectal cancer. Dis Colon Rectum 49: 1673-1683, 2006.
15. Morris EJ, Maughan NJ, Forman D and Quirke P: Identifying stage III colorectal cancer patients: The influence of the patient, surgeon, and pathologist. J Clin Oncol 25: 2573-2579, 2007.
16. Baxter NN, Vimig DJ, Rothenberger DA, Morris AM, Jessurun J and Virnig BA: Lymph node evaluation in colorectal cancer patients: A population-based study. J Natl Cancer Inst 97: 219-225, 2005.
17. Chou JF, Row D, Gonen M, Liu YH, Schrag D, Weiser MR: Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: A populationbased study. Cancer 116: 2560-2570, 2010.
18. Gonen M, Schrag D, Weiser MR: Nodal staging score: A tool to assess adequate staging of node-negative colon cancer. J Clin Oncol 27: 6166-6171, 2009.
19. Bilimoria KY, Bentrem DJ, Stewart AK, Talamonti MS, Winchester DP, Russell TR and Ko CY: Lymph node evaluation as a colon cancer quality measure: A national hospital report card. J Natl Cancer Inst 100: 1310-1317, 2008.
20. Wright FC, Gagliardi AR, Law CH, Last LD, Klevan AE, Hongjinda S, Stitt LW, Klar N, Ryan DP and Smith AJ: A randomized controlled trial to improve lymph node assessment in stage II colon cancer. Arch Surg 143: 1050-1055, 2008.
21. Fielding LP, Arsenault PA, Chapuis PH, Dent O, Gathright B, Hardcastle JD, Hermanek P, Jass JR and Newland RC: Clinicopathological staging for colorectal cancer: An International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol 6: 325-344, 1991.
22. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M and Willett C: Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124: 979-994, 2000.
23. McDonald JR, Renehan AG, O'Dwyer ST and Haboubi NY: Lymph node harvest in colon and rectal cancer: Current considerations. World J Gastrointest Surg 4: 9-19, 2012.
24. Baxter NN, Ricciardi R, Simunovic M, Urbach DR and Virnig BA: An evaluation of the relationship between lymph node number and staging in pT3 colon cancer using population-based data. Dis Colon Rectum 53: 65-70, 2010.
25. Wong JH, Johnson DS, Hemmings D, Hsu A, Imai T and Tominaga GT: Assessing the quality of colorectal cancer staging: Documenting the process in improving the staging of node-negative colorectal cancer. Arch Surg 140: 881-886, 2005.
26. Tsikitis VL, Larson DL, Wolff BG, Kennedy G, Diehl N, Qin R, Dozois EJ and Cima RR: Survival in stage III colon cancer is independent of the total number of lymph node retrieved. J Am Coll Surg 208: 42-47, 2009.
27. Kukreja SS, Esteban-Agusti E, Velasco JM and Hieken TJ: Increased lymph node evaluation with colorectal cancer resection: Does it improve detection of stage III disease? Arch Surg 144: 612-617, 2009.
28. Lee S, Hofmann LJ, Davis KG and Waddell BE: Lymph node evaluation of colon cancer and its association with improved staging and survival in the Department of Defense Health Care System. Ann Surg Oncol 16: 3080-3086, 2009.
29. Hashiguchi Y, Hase K, Ueno H, Mochizuki H, Kajiwara Y, Ichikura T and Yamamoto J: Prognostic significance of the number of lymph nodes examined in colon cancer surgery: Clinical application beyond simple measurement. Ann Surg 251: 872-881, 2010.
30. Bilchik A, Nissan A, Wainberg Z, Shen P, McCarter M, Protic M, Howard R, Elashoff D, Tyler J, Peoples GE and Stojadinovic A: Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in elderly colorectal cancer: An analysis of 2 international multicenter prospective trials. Ann Surg 252: 467-474, 2010.
31. Prandi M, Lionetto R, Biri A, Francioni G, Accarpio G, Anfossi A, Ballario E, Becchi G, Bonilauri S, Carobbi A, Cavaliere P, Garcea D, Giuliani L, Morziani E, Mosca F, Mussa A, Pasqualini M, Poddie D, Tonetti F, Zardo L and Rosso R: Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: Results of a secondary analysis of a large scale adjuvant trial. Ann Surg 235: 458-463, 2002.
32. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ and Haller DG: Colon cancer survival is associated with increasing number of lymph nodes analyzed: A secondary survey of intergroup trial INT-0089. J Clin Oncol 21: 2912-2919, 2003.
33. Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, MacDonald JS, Catalano PJ and Haller DG: Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 10: 213-218, 2003.
34. Bui L, Rempel E, Reeson D and Simunovic M: Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: A population-based study. J Surg Oncol 93: 439-445, 2006.
35. Vather R, Sammour T, Kahokehr A, Connolly AB and Hill AG: Lymph node evaluation and long-term survival in stage II and stage III colon cancer: A national study. Ann Surg Oncol 16: 585-593, 2009.
36. Chen SL and Bilchik AJ: More extensive nodal dissection improves survival for stage I to III colon cancer: A populationbased study. Ann Surg 244: 602-610, 2006.
37. Moore J, Hyman N, Callas P and Littenberg B: Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival. Surgery 147: 358-354, 2010.
38. Parsons HM, Tuttle TM, Kuntz KM, Begun JW, McGovern PM and Virnig BA: Association between lymph node evaluation for colon cancer and node positivity over the past 20 years. JAMA 306: 1089-1097, 2011.
39. Wong JH, Lum SS and Morgan JW: Lymph node couonts as an indicator of quality at the hospital level in colorectal cancer surgery. J Am Coll Surg 213: 226-230, 2011.
40. Kotake K, Honjo S, Sugihara K, Hashiguchi Y, Kato T, Kodaira S, Muto T and Koyama Y: Number of lymph nodes retrieved is an important determinant of survival of patients with stage II and stage III colorectal cancer. Jpn J Clin Oncol 42: 29-35, 2012.
41. Chang GJ, Rodriguez-Bigas MA, Skibber JM and Moyer VA: Lymph node evaluation and survival after curative resection of colon cancer: Systematic review. J Natl Cancer Inst 99: 433-441, 2007.
42. Shahrier M and Ahnen DJ: Colorectal cancer survival in Europe: The Will Rogers phenomenon revisited. Gut 47: 463-464, 2000.
43. George S, Primrose J, Talbot R, Smith J, Mullee M, Bailey D, du Boulay C and Jordan H: Wessex Colorectal Cancer Audit Working Group: Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists. Br J Cancer 95: 841-847, 2006.
44. Namm J, Ng M, Roy-Chowdhury S, Morgan JW, Lum SS and Wong JH: Quantitating the impact of stage migration on staging accuracy in colorectal cancer. J Am Coll Surg 207: 882-887, 2008.
45. Yu XQ, O'Connell DL, Gibberd RW, Abrahamowicz M and Armstrong BK: Misclassification of colorectal cancer stage and area variation in survival. Int J Cancer 122: 398-402, 2008.
46. Kelder W, Inberg B, Schaapveld M, Karrenbeld A, Grond J, Wiggers T and Plukker JT: Impact of the number of histologically examined lymph nodes on prognosis in colon cancer: A population-based study in the Netherlands. Dis Colon Rectum 52: 260-267, 2009.
47. Miki C, Inoue Y, Hiro J, Ojima E, Araki T, Uchida K and Kusunoki M: Combined measurement of hepatocyte growth factor and carcinoembryonic antigen as a prognostic marker for patients with Dukes' A and B colorectal cancer: Results of a five-year study. Dis Colon Rectum 49: 1710-1718, 2010.
48. Faerden AE, Sjo OH, Bukholm IR, Andersen SN, Svindland A, Nesbakken A and Bakka A: Lymph node micrometastases and isolated tumor cells influence survival in stage I and II colon cancer. Dis Colon Rectum 54: 200-206, 2011.
49. Koebrugge B, Vogelaar FJ, Lips DJ, Pruijt JF, van der Linden JC, Ernst MF and Bosscha K: The number of high-risk factors is related to outcome in stage II colonic cancer patients. Eur J Surg Oncol 37: 964-970, 2011.
50. Mroczkowski P, Schmidt U, Sahm M, Gastinger I, Lippert H and Kube R: Prognostic factors assessed for 15,096 patients with colon cancer in stage I and II. World J Surg 36: 1693-1698, 2012.
51. Csemi G, Vinh-Hung V and Burzykowski T: Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinoma? J Surg Oncol 81: 63-69, 2002.
52. Swanson RS, Compton CC, Stewart AK and Bland KI: The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 10: 65-71, 2003.
53. Bilimoria KY, Stewart AK, Palis BE, Bentrem DJ, Talamonti MS and Ko CY: Adequacy and importance of lymph node evaluation for colon cancer in the elderly. J Am Coll Surg 206: 247-254, 2008.
54. Bilimoria KY, Palis B, Stewart AK, Bentrem DJ, Freel AC, Sigurdson ER, Talamonti MS and Ko CY: Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum 51: 154-161, 2008.
55. Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB 3rd, Cummings B, Gunderson L, Macdonald JS and Mayer RJ: Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 19: 157-163, 2001.
56. Greene FL, Stewart AK and Norton HJ: New tumor-nodemetastasis staging strategy for node-positive (stage III) rectal cancer: an analysis. J Clin Oncol 22: 1778-1784, 2004.
57. Habr-Gama A, Perez RO, Proscurshim I, Rawet V, Pereira DD, Sousa AH, Kiss D and Cecconello I: Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: What does it mean? Dis Colon Rectum 51: 277-283, 2008.
58. Wang H, Safar B, Wexner S, Wang H, Safar B, Zhao R, Cruz- Correa M and Berho M: Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: Does the same standard apply? Dis Colon Rectum 52: 549-557, 2009.
59. Perez RO, Pereira DD, Proscurshim I, Gama-Rodrigues J, Rawet V, Sao Juliao GP, Kiss D, Cecconello I and Habr-Gama A: Lymph node size in rectal cancer following neoadjuvant chemoradiation: Can we rely on radiologic nodal staging after chemoradiation? Dis Colon Rectum 52: 1278-1284, 2009.
60. Taflampas P, Christodoulakis M, Gourtsoyianni S, Leventi K, Melissas J and Tsiftsis DD: The effect of preoperative chemoradiotherapy on lymph node harvest after total mesorectal excision for rectal cancer. Dis Colon Rectum 52: 1470-1474, 2009.
61. Marks JH, Valsdottir EB, Rather AA, Nweze IC, Newman DA and Chernick MR: Fewer than 12 lymph nodes can be expected in a surgical specimen after high-dose chemoradiation therapy for rectal cancer. Dis Colon Rectum 53: 1023-1029, 2010.
62. Klos CL, Shellito PC, Rather DW, Hodin RA, Cusack JC, Bordeianou L, Sylla P, Hong TS, Blaszkowsky L, Ryan DP, Lauwers GY, Chang Y and Berger DL: The effect of neoadjuvant chemoradiation therapy on the prognostic value of lymph nodes after rectal cancer surgery. Am J Surg 200: 440-445, 2010.
63. Ha YH, Jeong SY, Lim SB, Choi HS, Hong YS, Chang HJ, Kim DY, Jung KH and Park JG: Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer. Ann Surg 252: 336-340, 2010.
64. Kim YW, Kim NK, Min BS, Lee KY, Sohn SK and Cho CH: The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg 249: 965-972, 2009.
65. Tsai CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Krishnan S, Maru DM and Das P: Number of lymph node examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 117: 3713-2722, 2011.
66. Chang GJ, Rodriguez-Bigas MA, Eng C and Skibber JM: Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome. Cancer 115: 5432-5440, 2009.
67. Chapuis PH, Dent OF, Bokey EL, Newland RC and Sinclair G: Adverse histopathologic findings as a guide to patient management after curative resection of node-positive colonic cancer. Br J Surg 91: 349-354, 2004.
68. Chan CL, Chafai N, Rickard MJ, Dent OF, Chapuis PH and Bokey EL: What pathologic features influence survival in patients with local residual tumor after resection of colorectal cancer? J Am Coll Surg 199: 680-686, 2004.
69. Hida J, Okuno K, Yasutomi M, Yoshifuji T, Matsuzaki T, Uchida T, Ishimaru E, Tokoro T and Shiozaki H: Number versus distribution in classifying regional lymph node metastases from colon cancer. J Am Coll Surg 201: 217-222, 2005.
70. Suzuki O, Sekishita Y, Shiono T, Ono K, Fujimori M and Kondo S: Number of lymph node metastases is better predictor of prognosis than level of lymph node metastasis in patients with node-positive colon cancer. J Am Coll Surg 202: 732-736, 2006.
71. Kobayashi H, Ueno H, Hashiguchi Y and Mochizuki H: Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer. Surgery 139: 516-522, 2006.
72. Leibold T, Shia J, Minsky BD, Akhurst T, Gollub MJ, Ginsberg MS, Larson S, Riedel E, Wong WD and Guillem JG: Prognostic implications of the distribution of lymph node metastases in rectal cancer after neoadjuvant chemoradiotherapy. J Clin Oncol 26: 2106-2111, 2008.
73. Ang CW, Tweedle EM, Campbell F and Rooney PS: Apical node metastasis independently predicts poor survival in Dukes' C colorectal cancer. Colorectal Dis 13: 526-531, 2011.
74. Huh JW, Kim YJ and Kim HR: Distribution of lymph node metastases is an independent predictor of survival for sigmoid colon and rectal cancer. Ann Surg 255: 70-78, 2012.
75. Schumacher P, Dineen S, Bamelt C Jr, Fleming J and Anthony T: The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg 194: 827-831, 2007.
76. Lee HY, Choi HJ, Park KJ, Shin JS, Kwon HC, Roh MS and Kim C: Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol 14: 1712-1717, 2007.
77. Derwinger K, Carlsson G and Gustavasson B: A study of lymph node ratio as a prognostic marker in colon cancer. Eur J Surg Oncol 34: 771-775, 2008.
78. Peng J, Xu Y, Guan Z, Zhu J, Wang M, Cai G, Sheng W and Cai S: Prognostic significance of the metastatic lymph node ratio in node-positive rectal cancer. Ann Surg Oncol 15: 3118-123, 2008.
79. Peschaud F, Benoist S, Julie C, Beauchet A, Penna C, Rougier P and Nordlinger B: The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer. Ann Surg 248: 1067-1073, 2008.
80. Moug SJ, Saldanha JD, McGregor JR, Balsitis M and Diament RH: Positive lymph node retrieval ratio optimises patient staging in colorectal cancer. Br J Cancer 100: 1530-1533, 2009.
81. Vaccaro CA, Im V, Rossi GL, Quintana GO, Benati ML, Perez de Arenaza D and Bonadeo FA: Lymph node ratio as prognostic factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum 52: 1244-1250, 2009.
82. Park IJ, Choi GS and Jun SH: Nodal stage of stage III colon cancer: The impact of metastatic lymph node ratio. J Surg Oncol 100: 240-243, 2009.
83. Huh JW, Kim YJ and Kim HR: Ratio of metastatic to resected lymph nodes as a prognostic factor in node-positive colorectal cancer. Ann Surg Oncol 17: 2640-2646, 2010.
84. Qiu HB, Zhang LY, Li YF, Zhou ZW, Keshari RP and Xu RH: Ratio of metastatic to resected lymph nodes enhances to predict survival in patients with stage III colorectal cancer. Ann Surg Oncol 18: 1568-1574, 2011.
85. Sjo OH, Merok MA, Svindland A and Nesbakken A: Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer. Dis Colon Rectum 55: 307-315, 2012.
86. Persiani R, Cananzi FC, Biondi A, Paliani G, Tufo A, Ferrara F, Vigorita V and D'Ugo D: Log odds of positive lymph nodes in colon cancer: A meaningful ratio-based lymph node classification system. World J Surg 36: 667-674, 2012.
87. Stocchi L, Nelson H, Sargent DJ, O'Connell MJ, Tepper JE, Krook JE and Beart R Jr: North Central Cancer Treatment Group: Impact of surgical and pathological variables in rectal cancer: A United States Community and Cooperative Group report. J Clin Oncol 19: 3895-3902, 2001.
88. Edler D, Ohrling K, Hallstrom M, Karlberg M and Ragnhammar P: The number of analyzed lymph nodes: A prognostic factor in colorectal cancer. Acta Pathol 46: 975-981, 2007.
89. Jestin P, Pahlman L, Glimelius B and Gunnarsson U: Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination. Eur J Cancer 41: 2071-2078, 2005.
90. Berger AC, Sigurdson ER, Le Voyer T, Hanlon A, Mayer RJ, Macdonald JS, Catalano PJ and Haller DG: Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23: 8706-8712, 2005.
91. De Ridder M, Vinh-Hung V, Van Nieuwenhove Y, Hoorens A, Sermeus A and Storme G: Prognostic value of the lymph node ratio in node-positive colon cancer. Gut 55: 1681, 2006.
92. Mammen JM, James LE, Molloy M, Williams A, Wray CJ and Sussman JJ: The relationship of lymph node dissection and colon cancer survival in the Veterans Affairs Central Cancer Registry. Am J Surg 194: 349-354, 2007.
93. Rosenberg R, Friederichs J, Schuster T, Gertler R, Maak M, Becker K, Grebner A, Ulm K, Hofler H, Nekarda H and Siewert JR: Prognosis of patients with colorectal cancer is associated with lymph node ratio: A single-center analysis of 3,026 patients over a 25-year time period. Ann Surg 248: 968-978, 2008.
94. Rosenberg R, Engel J, Bruns C, Heitland W, Hermes N, Jauch KW, Kopp R, Putterich E, Ruppert R, Schuster T, Friess H and Holzel D: The prognostic value of lymph node ratio in a population-based collective of colorectal cancer patients. Ann Surg 251: 1070-1078, 2010.
95. Wang J, Hassett JM, Dayton MT and Kulaylat MN: Lymph node ratio: Role in the staging of node-positive colon cancer. Ann Surg Oncol 15: 1600-1608, 2008.
96. Wang J, Kulaylat M, Rockette H, Hassett J, Rajput A, Dunn KB and Dayton M: Should total number of lymph nodes be used as a quality of care for stage III colon cancer? Ann Surg 249: 559-563, 2009.
97. Chen SL, Steele SR, Eberhardt J, Zhu K, Bilchik A and Stojadinovic A: Lymph node ratio as aquality and prognostic indicator in stage III colon cancer. Ann Surg 253: 82-87, 2011.
98. Ceelen W, van Nieuwenhove Y and Pattyn P: Prognostic value of the lymph node ratio in stage III colorectal cancer: A systematic review. Ann Surg Oncol 17: 2847-2855, 2010.
99. Ogino S, Nosho K, Irahara N, Shima K, Baba Y, Kirkner GJ, Mino-Kenudson M, Giovannucci EL, Meyerhardt JA and Fuchs CS: Negative lymph node count is associated with survival of colorectal cancer patients, independent of tumoral molecular alterations and lymphocytic reaction. Am J Gastroenterol 105: 420-433, 2010.
100. Johnson PM, Porter GA, Ricciardi R and Baxter NN: Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol 24: 3570-3575, 2006.
101. Chang YJ, Chang YJ, Chen LJ, Chung KP and Lai MS: Evaluation of lymph nodes in patients with colon cancer undergoing colon resection: A population-based study. World J Surg 36: 1906-1914: 2012.